POMDOCTOR Accounts Payable

The latest accounts payable for POM is $45M as of December 2025. That compares with $25M in the prior-year period — up 76.8% year over year. Investors often review this figure alongside POMDOCTOR's historical trend and sector peers before judging valuation or financial health.

Over the past year, POM's accounts payable moved from $25M to $45M — a 76.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in POMDOCTOR's operating scale or balance-sheet position.

A accounts payable figure of $45M for POM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting POM's accounts payable ($45M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.